Multiple system atrophy (MSA) is a progressive disorder with limited treatment options. However, recent research has yielded potential insights into new therapeutic approaches. Current research centers on targeting the underlying causes of MSA. One avenue under investigation involves pharmacological interventions to modulate the dysregulation of s